We serve 3-Acetyl-5-chlorothiophene-2-sulfonamide CAS:160982-10-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: 3-Acetyl-5-chlorothiophene-2-sulfonamide
CAS.NO:160982-10-5
Synonyms:
3-Acetyl-5-chloro-2-thiophenesulfonamide
3-Acetyl-2-(aminosulfonyl)-5-chlorothiophene
Molecular Formula: C6H6ClNO3S2
Molecular Weight:239.70000
Physical and Chemical Properties:
Density: 1.583
Boiling point: 453ºC at 760 mmHg
Melting point: /
Flash point: 227.7ºC
Refractive index: 1.596
Specification:
Appearance: white powder
Purity:≥98%
Moisture Content: ≤0.1%
Impurity: ≤0.05%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Brinzolamide CAS:138890-62-7
Contact us for information like 3-Acetyl-5-chlorothiophene-2-sulfonamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Acetyl-2-(aminosulfonyl)-5-chlorothiophene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Acetyl-5-chlorothiophene-2-sulfonamide Use and application,3-Acetyl-2-(aminosulfonyl)-5-chlorothiophene technical grade,usp/ep/jp grade.
Related News: It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing.HC Blue 7 manufacturer It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing.2-(4-Methyl-2-phenyl-1-piperazinyl)-3-pyridinemethanol supplier Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).Bis(2-methoxyethyl)aminosulfur trifluoride vendor Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).Combining its core technological advantages such as ammonia oxidation, phosgenation, and fluorination, the company actively enters the field of fine and functional chemicals, and expands its focus to include polymer additives, replacement of phenolic polymer material monomers, and coating preservatives.
